+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients



Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients



International Journal of Radiation Oncology Biology Physics 60(4): 1098-1105



To assess the pelvic failure among patients with T3 rectal cancer treated with local excision after preoperative chemoradiation. Between January 1990 and June 2002, 431 patients with clinically staged T3 rectal cancer were treated with preoperative chemoradiation followed by surgical resection. Full-thickness local excision [Kraske (n = 3) or a transanal excision (n = 23)] was performed in 26 patients because of patient refusal of abdominoperineal resection (APR) (n = 13), medical comorbidity (n = 4), physician preference after a complete clinical response (n = 6), and other reasons (n = 3). All patients were treated with continuous-infusion 5-fluorouracil (5-FU) (300 mg/m(2) Monday to Friday) and concomitant pelvic radiation (45 Gy in 25 fractions with a 3-field belly board technique). Ten local-excision patients received a concomitant boost during the last week of therapy (1.5-Gy second daily fractions) for a total dose of 52.5 Gy. Similar preoperative treatment was followed by total mesorectal excision in 405 patients. Among the local-excision patients, the median tumor size was 3.5 cm (range, 0.5-7 cm). Well-differentiated or moderately-differentiated histology was present in all but 3 cases, and endoscopic ultrasound staging examination was performed in 25 of 26 patients. Based on CT findings, 1 patient was node positive. The median circumference involved by tumor was 33%, (20%-75%). The median distance from the anal verge was 3 cm (range, 1-8 cm). The mean follow-up was 46 months (range, 5-109 months) in the local-excision group. In the local-excision group, 19 of 26 patients had only residual scarring noted on digital rectal examination and rigid proctoscopy before surgery. Fourteen patients (54%) had a complete histologic response to chemoradiation, 9 patients (35%) had microscopic residual disease, and 3 patients (12%) had gross residual disease. Two intrapelvic recurrences occurred at 76 and 20 months among the 26 patients treated with local excision (6% 5-year actuarial pelvic recurrence rate). This rate compared with an 8% 5-year actuarial pelvic recurrence rate among T3 patients treated with mesorectal excision and a 6% pelvic recurrence rate in the subgroup of mesorectal-excision patients with a complete clinical response to preoperative chemoradiation. One additional local-excision patient recurred in an inguinal lymph node after local excision and subsequently died of metastatic disease. A total of 2 local-excision patients died of metastatic rectal cancer. Actuarial overall survival at 5 years was 86% in the local-excision group compared with 81% among mesorectal-excision patients (p = NS), and 85% in patients with a complete clinical response to chemoradiation followed by mesorectal excision by APR or LAR (p = NS). In an experience stimulated by patient refusal of APR, highly selected patients who responded well to conventional external-beam radiotherapy (CXRT) were selected to undergo local excision. Most of these patients had pathologic complete response. Local control and survival rates are comparable to those achieved with chemoradiation followed by mesorectal excision. This strategy should be prospectively studied in a group of patients with low rectal cancer who have no clinical evidence of tumor after chemoradiation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012273568

Download citation: RISBibTeXText

PMID: 15519780

DOI: 10.1016/j.ijrobp.2004.04.062


Related references

Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Annals of Surgical Oncology 17(2): 441-447, 2010

Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer. Diseases of the Colon and Rectum 57(11): 1245-1252, 2014

Transanal local excision for preoperative concurrent chemoradiation therapy for distal rectal cancer in selected patients. Surgery Today 37(12): 1068-1072, 2007

Preoperative radiotherapy and local excision of rectal cancer: Long-term results of a randomised study. RadioTherapy and Oncology 127(3): 396-403, 2018

Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Annals of Surgical Oncology 18(13): 3686-3693, 2011

Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study. International Journal of Radiation Oncology Biology Physics 79(4): 1171-1178, 2011

Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. British Journal of Surgery 93(10): 1215-1223, 2006

Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer. World Journal of Surgery 36(10): 2481-2487, 2012

Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer. International Journal of Radiation Oncology Biology Physics 66(4): 1143-1151, 2006

Results of long-term follow-up after local excision for well-selected low rectal cancers. Revista Espanola de Enfermedades Digestivas 99(4): 206-209, 2007

A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Diseases of the Colon and Rectum 46(3): 298-304, 2003

Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified. International Journal of Colorectal Disease 33(4): 487-491, 2018

Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. Journal of Gastrointestinal Surgery 9(1): 90-9; Discussion 99-101, 2005

Long-term results of preoperative 5-fluorouracil-oxaliplatin chemoradiation therapy in locally advanced rectal cancer. Anticancer Research 33(2): 725-730, 2013

Long-term oncologic results of patients with distal rectal cancer treated by local excision with or without adjuvant treatment. International Journal of Colorectal Disease 22(11): 1325-1330, 2007